Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.08
Delayed Data
As of Aug 29
 0.00 / 0.00%
Today’s Change
5.49
Today|||52-Week Range
9.54
+2.67%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.08
Today’s openn.a.
Day’s range-- - --
Volume1,805
Average volume (3 months)478,743
Market cap$629.4M
Dividend yield--
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+121.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.35+3.48%
FMIFoundation Medicine ...+0.40+1.88%
GHDXGenomic Health Inc-0.23-0.87%
RDNTRadNet Inc+0.08+1.21%
Data as of 9:50am ET, 08/30/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Search for Jobs